A detailed history of Tranquilli Financial Advisor LLC transactions in Novartis Ag stock. As of the latest transaction made, Tranquilli Financial Advisor LLC holds 4,392 shares of NVS stock, worth $475,346. This represents 0.28% of its overall portfolio holdings.

Number of Shares
4,392
Previous 4,720 6.95%
Holding current value
$475,346
Previous $476,000 10.92%
% of portfolio
0.28%
Previous 0.34%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$95.27 - $108.47 $31,248 - $35,578
-328 Reduced 6.95%
4,392 $424,000
Q4 2023

Feb 14, 2024

SELL
$92.27 - $101.54 $26,942 - $29,649
-292 Reduced 5.83%
4,720 $476,000
Q3 2023

Nov 08, 2023

BUY
$94.73 - $105.13 $35,239 - $39,108
372 Added 8.02%
5,012 $510,000
Q2 2023

Jul 27, 2023

BUY
$92.52 - $104.91 $1,757 - $1,993
19 Added 0.41%
4,640 $468,000
Q1 2023

May 15, 2023

BUY
$80.03 - $92.81 $26,409 - $30,627
330 Added 7.69%
4,621 $425,000
Q4 2022

Feb 08, 2023

BUY
$75.55 - $92.52 $74,794 - $91,594
990 Added 29.99%
4,291 $389,000
Q3 2022

Nov 02, 2022

BUY
$74.61 - $87.26 $246,287 - $288,045
3,301 New
3,301 $251,000
Q2 2022

Aug 15, 2022

SELL
$80.52 - $93.75 $187,853 - $218,718
-2,333 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $2,643 - $2,990
-33 Reduced 1.39%
2,333 $205,000
Q4 2021

Feb 10, 2022

SELL
$79.7 - $88.13 $9,803 - $10,839
-123 Reduced 4.94%
2,366 $207,000
Q3 2021

Nov 10, 2021

BUY
$81.78 - $95.14 $5,479 - $6,374
67 Added 2.77%
2,489 $204,000
Q2 2021

Aug 09, 2021

SELL
$85.24 - $94.15 $1,193 - $1,318
-14 Reduced 0.57%
2,422 $221,000
Q1 2021

May 17, 2021

SELL
$83.5 - $98.47 $13,193 - $15,558
-158 Reduced 6.09%
2,436 $208,000
Q4 2020

Feb 25, 2021

BUY
$78.07 - $94.43 $202,513 - $244,951
2,594 New
2,594 $245,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Tranquilli Financial Advisor LLC Portfolio

Follow Tranquilli Financial Advisor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tranquilli Financial Advisor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tranquilli Financial Advisor LLC with notifications on news.